Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 7, Pages 2031-2036
Publisher
Oxford University Press (OUP)
Online
2016-03-24
DOI
10.1093/jac/dkw056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Achieving Target Voriconazole Concentrations More Accurately in Children and Adolescents
- (2015) Michael Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole phototoxicity in children: A retrospective review
- (2015) Johanna Sheu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections
- (2015) Hyun Mi Kang et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Autoinduction of Voriconazole Metabolism in a Child with Invasive Pulmonary Aspergillosis
- (2015) Alice Jenh Hsu et al. PHARMACOTHERAPY
- Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch Regimens in Immunocompromised Japanese Pediatric Patients
- (2014) Masaaki Mori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
- (2014) Andreas H Groll et al. LANCET ONCOLOGY
- Phototoxic dermatoses in pediatric BMT patients receiving voriconazole
- (2014) Rakesh K. Goyal et al. PEDIATRIC BLOOD & CANCER
- Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit
- (2013) S. Yunus et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Correlation of CYP2C19 Phenotype With Voriconazole Plasma Concentration in Children
- (2013) Atsushi Narita et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Highly Variable Plasma Concentrations of Voriconazole in Pediatric Hematopoietic Stem Cell Transplantation Patients
- (2012) Imke H. Bartelink et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and Adults
- (2012) Lena E. Friberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy
- (2012) J. R. Hansford et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients
- (2012) S. Pieper et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis
- (2012) Sophia L. Markantonis et al. Journal of Cystic Fibrosis
- Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis
- (2012) Soo-Han Choi et al. PEDIATRIC BLOOD & CANCER
- Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults
- (2011) Timothy A. Driscoll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study
- (2011) P. Soler-Palacin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients
- (2010) C. Michael et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children
- (2010) T. J. Walsh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Photosensitivity in Immunocompromised Patients Receiving Long-term Therapy With Oral Voriconazole
- (2010) Marie Antoinette Frick et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine
- (2009) B. Moriyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation
- (2009) Hedwig Kolve et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Penetration of Voriconazole, 1%, Eyedrops Into Human Aqueous Humor
- (2008) David Lau ARCHIVES OF OPHTHALMOLOGY
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started